Attachment

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl 2014-25231 CRADA 11/21/2016] 11/21/2019 I NovaDigm Therapeutics, Inc. [US] Steven Holland 2014-25232 _|CTA- Clinical Trial Agreement 2/19/2015 MERCK SHARP AND DOHME RESEARCH LABS. H Clifford Lane 2014-25261 Research Collaboration Agreement 1/12/2015) 1/8/2025] Regeneron Pharmaceuticals, Inc. Michael Lenardo 2014-25261 Research Collaboration Agreement 1/12/2015 1/8/2025] Regeneron Pharmaceuticals, Inc. 2014-25261 Research Collaboration Agreement 1/12/2015) 1/8/2025] Regeneron Pharmaceuticals, Inc. 2014-25261 |Research Collaboration Agreement 1/12/2015 1/8/2025] Regeneron Pharmaceuticals, Inc. 2014-25261 Research Collaboration Agreement 1/12/2015) 1/8/2025] Regeneron Pharmaceuticals, Inc. Michael Lenardo 2014-25285 = |Gift 3/13/2015} Tradition Foundation Byron Caughey 2014-25288 I CTA- Clinical Trial Agreement 3/10/2015 MAPP BIOPHARMACEUTICAL, INC. Richard Davey American Academy of Allergy Asthma and 2014-25299 |Gift 5/7/2015] 6/25/2016}Immunology Pamela Guerrerio GlaxoSmithKline Investigacion y Desarrollo (GSK) 2014-25305 |CRADA 9/7/2015 9/7/2018} [ES] Clifton Barry 2014-25326 |CRADA 9/28/2015] 9/28/2021|Merck Sharp & Dohme Corp 2014-25326 |CRADA 9/28/2015] 9/28/2021}Merck Sharp & Dohme Corp Michael Lenardo 2014-25326 |CRADA 9/28/2015| 9/28/2021}Merck Sharp & Dohme Corp Michael Lenardo 2014-25326 |CRADA 9/28/2015} 9/28/2021|Merck Sharp & Dohme Corp 2014-25327 _| Research Collaboration Agreement 4/17/2015] 4/17/2018] Third Medical University [CN] 2014-25327 Research Collaboration Agreement 4/17/2015} 4/17/2018] Third Medical University [CN] 2015-25099 _ |Research Collaboration Agreement 1/15/2016] 1/15/2018]Selecta Biosciences Patrick Duffy Aquarius Biotechnologies Inc. (purchased by 2015-25129 I CTA- Clinical Trial Agreement 4/30/2015 Matinas Biopharma) [US] 2015-25149 |Gift 8/3/2015) 4/1/2019] Cancer Research Institute [US] 2015-25149 |Gift 8/3/2015} 4/1/2019] Cancer Research Institute [US] 2015-25153 _| Letter of Intent/MOU 1/29/2015) University of Minho (Universidade do Minho) [PT] _|Michael Otto 2015-25172 |CRADA 10/29/2015] 1/15/2023) Bristol-Myers Squibb Company (BMS) Peter Sun GlaxoSmithKline Biologicals SA (GSK Biologicals, 2015-25194 |Research Collaboration Agreement 7/22/2015} 7/22/2018]|GSK) [BE] Patrick Duffy GlaxoSmithKline Biologicals SA (GSK Biologicals, 2015-25197 _|CTA- Clinical Trial Agreement 2/13/2015} GSK) [BE] H Clifford Lane 2015-25249 _|Letter of Intent/MOU 2/18/2015 University of Michigan Michael Otto Harvard University (The President and Fellows of 2015-25269 _|Gift 4/30/2015} Harvard College)